Titre:
  • Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.
Auteur:Bouchart, Christelle; Navez, Julie; Borbath, Ivan; Geboes, Karen; Vandamme, Timon; Closset, Jean; Moretti, Luigi; Demetter, Pieter; Paesmans, Marianne; Van Laethem, Jean-Luc
Informations sur la publication:BMC cancer, 23, 1, page (891)
Statut de publication:Publié, 2023-09-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Borderline resectable
Chemotherapy
Clinical trial
FOLFIRINOX
Neoadjuvant therapy
Pancreatic adenocarcinoma
Stereotactic body radiation
MeSH keywords:Humans
Gemcitabine
Adenocarcinoma -- therapy
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Quality of Life
Radiosurgery -- adverse effects
Pancreatic Neoplasms -- drug therapy -- radiotherapy
Randomized Controlled Trials as Topic
Multicenter Studies as Topic
Clinical Trials, Phase II as Topic
Langue:Anglais
Identificateurs:urn:issn:1471-2407
info:doi/10.1186/s12885-023-11327-x
info:pii/10.1186/s12885-023-11327-x
info:pmid/37735634
PMC10512504